-
Signature
-
/s/ John S. Hess, Jr. under Power of Attorney
-
Issuer symbol
-
UTHR
-
Transactions as of
-
29 May 2025
-
Transactions value $
-
-$2,057,785
-
Form type
-
4
-
Filing time
-
30 May 2025, 16:30:41 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| MAHON PAUL A |
EVP & GENERAL COUNSEL |
C/O UNITED THERAPEUTICS CORPORATION, 1000 SPRING STREET, SILVER SPRING |
/s/ John S. Hess, Jr. under Power of Attorney |
30 May 2025 |
0001231589 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
UTHR |
Common Stock |
Options Exercise |
$948K |
+7K |
+19.03% |
$135.42 |
43.8K |
29 May 2025 |
Direct |
F1 |
| transaction |
UTHR |
Common Stock |
Options Exercise |
$471K |
+4K |
+9.14% |
$117.76 |
47.8K |
29 May 2025 |
Direct |
F1 |
| transaction |
UTHR |
Common Stock |
Sale |
-$1.26M |
-4K |
-8.37% |
$315.77 |
43.8K |
29 May 2025 |
Direct |
F1 |
| transaction |
UTHR |
Common Stock |
Sale |
-$30.8K |
-99 |
-0.23% |
$311.14 |
43.7K |
29 May 2025 |
Direct |
F1 |
| transaction |
UTHR |
Common Stock |
Sale |
-$31.7K |
-101 |
-0.23% |
$313.46 |
43.6K |
29 May 2025 |
Direct |
F1, F2 |
| transaction |
UTHR |
Common Stock |
Sale |
-$537K |
-1.7K |
-3.91% |
$315.53 |
41.9K |
29 May 2025 |
Direct |
F1, F3 |
| transaction |
UTHR |
Common Stock |
Sale |
-$1.45M |
-4.57K |
-10.92% |
$316.57 |
37.3K |
29 May 2025 |
Direct |
F1, F4 |
| transaction |
UTHR |
Common Stock |
Sale |
-$166K |
-524 |
-1.4% |
$317.19 |
36.8K |
29 May 2025 |
Direct |
F1, F5 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
UTHR |
Stock Option |
Options Exercise |
$0 |
-7K |
-4.67% |
$0.00 |
143K |
29 May 2025 |
Common Stock |
7K |
$135.42 |
Direct |
F1 |
| transaction |
UTHR |
Stock Option |
Options Exercise |
$0 |
-4K |
-100% |
$0.00 |
0 |
29 May 2025 |
Common Stock |
4K |
$117.76 |
Direct |
F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: